Anja Seckinger

Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood

Wolfgang Wagner, Frederik Wein, Anja Seckinger et al. · Experimental Hematology · 2005 · 1.2K citations · Full text

Regenerative Medicine, Tissue Engineering, Developmental Biology +15

Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment

Anja Seckinger, Jose Antonio Delgado, Samuel Moser et al. · Cancer Cell · 2017 · 305 citations · Full text

Hematological Malignancy, Cancer Immunosurveillance, Multiple Myeloma Treatment +8

Progression in Smoldering Myeloma Is Independently Determined by the Chromosomal Abnormalities del(17p), t(4;14), Gain 1q, Hyperdiploidy, and Tumor Load

Kai Neben, Anna Jauch, Thomas Hielscher et al. · Journal of Clinical Oncology · 2013 · 232 citations · Full text

Translocation t(11;14) Is Associated With Adverse Outcome in Patients With Newly Diagnosed AL Amyloidosis When Treated With Bortezomib-Based Regimens

Tilmann Bochtler, Ute Hegenbart, Christina Kunz et al. · Journal of Clinical Oncology · 2015 · 224 citations · Full text

Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma

Dirk Hose, Thierry Rème, Thomas Hielscher et al. · Haematologica · 2010 · 201 citations · Full text